NeoStem, Inc. Establishes Melanoma Scientific Advisory Board To Support Anticipated Phase 3 Trial

NeoStem, Inc. , a leader in the emerging cellular therapy industry, announced today its establishment of a melanoma scientific advisory board consisting of internationally renowned experts in oncology and in the development of novel therapeutics for melanoma. The group of six experts, including medical oncologists, a basic scientist, and a surgical oncologist specializing in melanoma, will advise and provide support to NeoStem in the area of melanoma research and clinical development.

http://ift.tt/1rM3hSM